Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease

Update Il y a 4 ans
Reference: NCT02847650

Woman and Man

Extract

The purpose of this study is to evaluate the efficacy, safety and tolerability of PF-06649751 in Parkinson's disease patients at early stage of the disease.


Inclusion criteria

  • Parkinson disease


Links